Matt Cohen - Profile and Investment Details

Investor Profile

Matt Cohen is a University Program, Venture Capital based in United States with a diverse investment portfolio that includes companies such as CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma, Artizan Biosciences, Medisix Therapeutics, Hyalex Orthopaedics, Aerovate Therapeutics, Quantum Circuits, NuMat Technologies, Embodied, Ambiq Micro, PMV Pharmaceuticals, Aptinyx, Fortis Therapeutics, Homology Medicines, Landos Biopharma, Cleave Therapeutics, Pionyr Immunotherapeutics, Perceptive Automata, Cyteir Therapeutics, Censys, Everactive, Precision BioSciences, Lastline, Clinipace, Algorithmia, SiFive, KenSci, Palladio Biosciences, EGenesis, IonQ, Merganser Biotech, Elementary Robotics, Kymeta, Selecta Biosciences, Iconic Therapeutics, Blade Therapeutics, Vector Launch, Biohaven Pharmaceutical, Millendo Therapeutics, Delfi Diagnostics, Seismos, Atsena Therapeutics, DiCE Molecules, Cell Design Labs, MC10, Picwell, Escient Pharmaceuticals, Spero Therapeutics, Capella BioScience, LunaPBC, Menlo Security, Antiva Biosciences, Effector Therapeutics, StreetLight Data, Satsuma Pharmaceuticals, Arrakis Therapeutics, Bristol-Myers Squibb, Q32 Bio, Corelight, ReCode Therapeutics, LunaDNA, Beam Therapeutics, Synthorx, ESCAPE Bio, Ribon Therapeutics, Neuros Medical. Over time, Matt Cohen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Matt Cohen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Training, Genetics, Payments, Cybersecurity, Women Founded, Medical Testing, Life Science, Information Technology (IT), Biotech, Medical Device, Healthcare, Biotechnology, Genomics, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Matt Cohen, as their portfolio suggests a familiarity and interest in this area.

Understanding Matt Cohen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.